| Products | Category | CAS No. | Approvals |
| Abiraterone acetate | Prostatic cancer | 154229-18-2 | USDMF No.: 26779,FDA approved |
| Adefovirpivoxil | Antivirals | 142340-99-6 | GMP |
| Alogliptin Benzoate | Anti-Diabetic | 850649-62-6 | USDMF 27993 |
| Amlodipine Besylate | Ion channel modulators | 111470-99-6 | USDMF 21951, FDA approved. |
| Aripiprazole | Schizophrenia | 129722-12-9 | GMP |
| Azilsartan Kamedoxomil | Hypertension | 863031-24-7 | USDMF 29818 |
| Azithromycin Bitterless | Antibiotic | 83905-01-05 | Technical Package available |
| Bacitracin, injectable. | Antibiotics | 1405-87-4 | USDMF 23999, GMP, FDA approved |
| Bisoprololfumarate | Hypertension | 104344-23-2 | EP,CP |
| Bivalirudin | Antithrombotics | 128270-60-0 | USDMF 24257, FDA approved |
| Bortezomib | Cancer | 179324-69-7 | DMF to be filed |
| Brinzolamide | Ophthalmic | 138890-62-7 | USDMF 23789, Canadian DMF,ASMF, FDA will inspect( From ALP), EDMF Available (From Duke Chem), |
| Bromfenac Sodium | Anti-inflammatory | 120638-55-3 | USDMF 23031 FDA Approved, Canada DMF,2010-198,ASMF, Japan DMF, EDMF |
| Canagliflozin | Diabetes | 842133-18-0 | USDMF No.: 30853 |
| Calcipotriene anhydrous | Vitamin | 112965-21-6 | USDMF 21943 |
| Calcipotriene monohydrate | Vitamin | 147657-22-5 | USDMF 27222 |
| Carfilzomib | Cancer | 868540-17-4 | USDMF No.: 030162 |
| Cetrorelix Acetate | Gonadotropins and GnRH | 120287-85-6 | USDMF No.:029849,FDA approved |
| CidofovirDihydrate | Antiviral | 149394-66-1 | USDMF 23446, DMF reviewed, FDA Approved, Canada DMF, 2012-031, ASMF. DMF fee paid. |
| Cilostazol | Antithrombotics | 73963-72-1 | USDMF 25666,FDA Approved, Canada DMF,GMP |
| Cinchocaine/Dibucaine Hydrochloride | A local anesthetic | 61-12-1 | EP |
| Clindamycin hydrochloride | Antibotics | 21462-39-5 | USP, EP,CP |
| Clindamycin palmitate hydrochloride | Antibiotics | 25507-04-4 | USP, EP,CP |
| Clindamycin phosphate | Antibiotics | 24729-96-2 | USP,EP |
| Cloxacillin sodium | Antibiotics | 7081-44-9 | GMP |
| DabigatranEtexilate | Anticoagulant | 211915-06-9 | China Registration filed |
| Dapagliflozin Propanediol | Anti-Diabetic | 960404-48-2. | USDMF 27838 |
| Dasatinib | Chemotherapeutic Agents | 302962-49-8 | USDMF No.:29505 |
| Diacerein | Anti-Arthritic | 13739-02-1 | EDMF Available |
| Dibucaine/Cinchocaine Base | A local anesthetic | 85-79-0 | USP |
| Dorzolamide HCl | Anti-Glaucoma | 130693-82-2 | USP/EP grade, EDMF Available |
| Doxapram Hydrochloride | Respiratory stimulant | 113-07-5 | 29848 |
| Doxercalciferol | Vitamin | 54573-75-0 | USDMF 25148,Canadian DMF,ASMF |
| Dronedarone Hydrochloride | Antiarrhythmic agent | 141625-93-6 | USDMF 28200. FDA approved |
| Duloxetine HCl | Anti-Depressant | 144060-53-7 | Under Development |
| Dutasteride | BPH | 164656-23-9 | China Registration filed |
| Eptifibatide | Antithrombotics | 188627-80-7 | USDMF 23786,DMF reviewed, FDA approved, Canadian DMF,ASMF |
| Empagliflozin | Anti-diabetic | 864070-44-0 | 29796 |
| Enoxaparin sodium | Antithrombotics | 9005-49-6 | GMP |
| Etofenamate | Anti-Inflammatory | 30544-47-9 | EDMF & CEP Available |
| Febuxostat | For treatment of gout and hyperuricemia. | 144060-53-7 | USDMF 25664, ASMF, FDA will inspect ( From ALP), |
| Ferric carboxymaltose | Anaemia | 9007-72-1 | DMF to be filed |
| Furbenicillin sodium | Antibiotics | GMP | |
| Goserelin Acetate | Gonadotropins and GnRH | 65807-02-5 | 029713, FDA approved |
| Imepenem + Cilastin (Sterile) | Antibacterial | GMP | |
| Imipenem( Sterile) | Antibacterial | USDMF: 31777 | |
| Iron sucrose | Anaemia | 8047-67-4 | USDMF No.: 18390 |
| Ivabradine Hydrochloride | Cardiovascular Agent | 148849-67-6 | USDMF No.: 28658 |
| Lanreotide Acetate | Peptidergics | 74381-53-6 | USDMF 24378 FDA Approved facility, Canadian DMF, ASMF |
| LapatinibDitosylate | Chemotherapeutic Agent | 388082-78-8 | 29712 |
| Latanoprost | Anti-Glacucoma | 130209-82-4 | EDMF |
| Liraglutide | Anti-Diabetic | 204656-20-2 | FDA approved on Sep.24, 2014. |
| Lornoxicam | NSAIDS | 70374-39-9 | CP |
| LoteprednolEtabonate | Glucocorticoids and Antiglucocorticoids | 82034-46-6 | USDMF 22278, FDA Approved facility, Canadian DMF, ASMF |
| Lurasidone Hydrochloride | Antipsychotics | 367514-88-3 | USDMF 27584, FDA twice Approved facility |
| Mesalamine | Anti-Diarrheal | 89-57-6 | 024256, CEP approved. Canadian DMF 2015-141 |
| Methylnaltrexone bromide | Opioid induced Constipation | 73232-52-7 | DMF in preparation |
| Mezlocillin sodium | Antibiotics | 59798-30-0 | GMP |
| Nepafenac | Non-steroidal anti-inflammatory drugs | 78281-72-8 | USDMF 23032, FDA Approved facility, Canada DMF 2012-035 |
| Nimodipine | Vasodilator Cerebral | 66085-59-4 | EDMF Available |
| Nitazoxanide | Antihelmintic | 55981-09-4 | EDMF Available |
| Oxacillin sodium | Antibacterials | 66-79-5 | GMP |
| Palonosetron Hydrochloride | Antiemetics | 135729-62-3 | USDMF, 23209, FDA Approved. Canada DMF 2012-032,GMP |
| Paricalcitol | Vitamin | 131918-61-1 | USDMF 21255,Canadian DMF,ASMF |
| Pemetrexed Disodium | Cancer | 150399-23-8 | USDMF No.: 22141,USFDA audited |
| Pidotimod | Immunositmulant | 121808-62-6 | CP |
| PirisudanolDimaleate | Anti- Depressant | 53659-00-0 | EDMF Available |
| Roflumilast | For chronic obstructive pulmonary disease | 162401-32-3 | USDMF 27779 |
| Saxagliptin Hydrochloride | Anti-Diabetic | 709031-78-7 | USDMF No.:29299 |
| Silodosin | Prostatic Hyperplasia | 158930-17-7 | USDMF : 027082 |
| Sitagliptin Phosphate Monohydrate | Anti-Diabetic | 654671-77-9 | USDMF No.:28325 |
| Sodium Bicarbonate( Sterile) | 144-55-8 | GMP | |
| Sofosbuvir | Anti- Viral | 1190307-88-0 | USDMF No.:28919 |
| Sulbenicillin sodium | Antibiotics | 28002-18-8 | GMP |
| Tamsulosin Hydrochloride | Drugs used in benign prostatic hyperplasia | 106463-17-6 | DMF2013-014, 21951, FDA inspected in July 2015 and approved. |
| Tranexamic Acid | Antihemorrhagics | 1197-18-8 | USDMF 22277, FDA Approved, DMF reviewed, Canada DMF2009-178, GMP, EDQM approved. |
| Tropicamide | Mydriasis-eye drops | 1508-75-4 | EP |
| Vildagliptin | Anti-Diabetic | 274901-16-5 | USDMF No.:28133 |
| Vecuronium bromide | Muscle Relaxants | 50700-72-6 | GMP |
| Vortioxetine Hydrochloride | Anti-depressant | USDMF No.: 029849 | |
| ZoledronicAcid,monohydrate | Drugs for treatment of bone diseases | 165800-06-6 | USDMF 23847, GMP, ASMF, US FDA inspected on Aug 19 to 23, 2013 only 2 483s and approved on Sep.12, 2014. |
| APIs Under Development | |||
| Products | Category | CAS No. | Approvals |
| Alprostadil | Vasodilator | 745-65-3 | Pipeline product |
| AripiprazoleLauroxil | Schizophrenia | 1259305-29-7 | Lab scale |
| Apremilast | Psoriasis | 608141-41-9 | Pilot Batch |
| Bimatoprost | Anti-Glacucoma | 155206-00-1 | Development Stage |
| CarboprostTrometamol | Prostanoid signaling modulators | 58551-69-2 | Development Stage |
| Doripenem | Antibiotic | 148016-81-3 | Lab R&D |
| Dinoprost | Prostanoid signaling modulators | 38562-01-5 | Development Stage |
| Duloxetine HCl | 116539-59-4 | Development Stage | |
| Ertapenem | Antibiotic | 153832-46-3 | Lab R&D |
| Ferric Citrate | Hyperphosphatemia | 2338-05-8 | Pilot batch |
| Ferric Maltol | Anaemia | 33725-54-1 | Lab Scale |
| Ferric Pyrophosphate | Anaemia | 10058-44-3 | Lab Scale |
| Ferumoxytol | Anaemia | 722492-56-0 | Lab Scale |
| Fingolimod | Multiple Sclerosis | 162359-55-9 | Development Stage |
| Frovatriptan Succinate Monohydrate | Anti- Migraine | 158930-17-7 | Development Stage |
| Misoprostol | AINS | 59122-46-2 | Pipeline product |
| Prasugrel | Cardiovascular Thrombosis | 150322-43-3 | Under Development |
| Travoprost | Antiglaucoma | 130209-82-4 | Development Stage |
| Treprostinil | Vasodilator | 81846-19-7 | Pipeline product |
Copyright © 2024 CAD Pharma Inc.